Clinical trial IJB_2743
Phase I/II trial of S81694 administered intravenously in combination with paclitaxel to evaluate the safety, pharmacokinetic and efficacy in metastatic breast cancer
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1 |
Academic trial | Non |
Sponsor | Servier |
EudraCT Identifier | 2017-002459-27 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03411161 |
Inclusion criteria | Metastatic first line RECIST 1.1 |
Last update |